Cargando…

Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

BACKGROUND: For patients with heart failure, prescription of loop diuretics (LD) and of higher doses are associated with an adverse prognosis. We investigated LD dose trajectories and their associations with outcomes in patients with dilated cardiomyopathy (DCM). METHODS: Associations between outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuzzi, Vincenzo, Cannatà, Antonio, Pellicori, Pierpaolo, Manca, Paolo, Stolfo, Davide, Gregorio, Caterina, Barbati, Giulia, Bromage, Daniel I., McDonagh, Theresa, Cleland, John G. F., Merlo, Marco, Sinagra, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998319/ https://www.ncbi.nlm.nih.gov/pubmed/36385396 http://dx.doi.org/10.1007/s00392-022-02126-8

Ejemplares similares

Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications
por: Nuzzi, Vincenzo, et al.
Publicado: (2022)

Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy
por: Lalario, Andrea, et al.
Publicado: (2022)

The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child
por: Manca, Paolo, et al.
Publicado: (2022)

Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling
por: Cannata, Antonio, et al.
Publicado: (2020)

Reshaping care in the aftermath of the pandemic. Implications for cardiology health systems
por: Jordan-Rios, Antonio, et al.
Publicado: (2023)

Dilated Cardiomyopathy With Mid‐Range Ejection Fraction at Diagnosis: Characterization and Natural History
por: Gentile, Piero, et al.
Publicado: (2019)

Dilated Cardiomyopathy: A Paradigm of Revolution in Medicine
por: Merlo, Marco, et al.
Publicado: (2020)

Natural History of Dilated Cardiomyopathy in Children
por: Puggia, Ilaria, et al.
Publicado: (2016)

Persistent Recovery of Normal Left Ventricular Function and Dimension in Idiopathic Dilated Cardiomyopathy During Long‐Term Follow‐up: Does Real Healing Exist?
por: Merlo, Marco, et al.
Publicado: (2015)

Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences
por: Castrichini, Matteo, et al.
Publicado: (2020)

Cardiovascular Damage in COVID-19: What We Know Two Years Later
por: Nuzzi, Vincenzo, et al.
Publicado: (2022)

Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy
por: Gregorio, Caterina, et al.
Publicado: (2022)

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy
por: Cittar, Marco, et al.
Publicado: (2021)

Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role
por: Pezzato, Andrea, et al.
Publicado: (2023)

The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic
por: Bromage, Daniel I., et al.
Publicado: (2020)

Role of Titin Missense Variants in Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2015)

Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together
por: Cannata’, Antonio, et al.
Publicado: (2019)

Treatment of Iron Deficiency in Heart Failure
por: Shamsi, Aamir, et al.
Publicado: (2023)

Temporal trends in decompensated heart failure and outcomes during COVID‐19: a multisite report from heart failure referral centres in London
por: Cannatà, Antonio, et al.
Publicado: (2020)

Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives
por: Merlo, M., et al.
Publicado: (2018)

Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life‐Threatening Arrhythmias
por: Spezzacatene, Anita, et al.
Publicado: (2015)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy
por: Pio Loco detto Gava, Carola, et al.
Publicado: (2023)

Toward a diagnostic CART model for Ischemic heart disease and idiopathic dilated cardiomyopathy based on heart rate total variability
por: Accardo, Agostino, et al.
Publicado: (2022)

Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy
por: Bertero, Edoardo, et al.
Publicado: (2023)

Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy
por: Aleksova, Aneta, et al.
Publicado: (2017)

Syncope in ICD recipients: a single centre experience
por: Khan, Parisha, et al.
Publicado: (2023)

Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction
por: Aleksova, Aneta, et al.
Publicado: (2019)

Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Autophagy and Inflammasome Activation in Dilated Cardiomyopathy
por: Caragnano, Angela, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis
por: Cannata, Antonio, et al.
Publicado: (2021)

Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy
por: Campbell, Nzali, et al.
Publicado: (2013)

Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
por: Stolfo, Davide, et al.
Publicado: (2022)

Long‐term outcomes after heart failure hospitalization during the COVID‐19 pandemic: a multisite report from heart failure referral centers in London
por: Ta Anyu, Anawinla, et al.
Publicado: (2021)

Patients hospitalised with heart failure across different waves of the COVID-19 pandemic show consistent clinical characteristics and outcomes
por: Rind, Irfan A., et al.
Publicado: (2022)

Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences
por: Verdonschot, Job A J, et al.
Publicado: (2020)

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
por: Asselbergs, Folkert W., et al.
Publicado: (2020)

FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sk7pj3ucopf9v548iau62ci0ua